APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dimethyl Fumarate Delayed-release Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dimethyl Fumarate Delayed-release Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025199 pages

Choose your research edition.

Industry ResearchDimethyl Fumarate Delayed-release Capsules Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Dimethyl Fumarate Delayed-release Capsules Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Dimethyl Fumarate Delayed-release Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dimethyl Fumarate Delayed-release Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Dimethyl Fumarate Delayed-release Capsules Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Dimethyl Fumarate Delayed-release Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Dimethyl Fumarate Delayed-release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dimethyl Fumarate Delayed-release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dimethyl Fumarate Delayed-release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dimethyl Fumarate Delayed-release Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dimethyl Fumarate Delayed-release Capsules include Teva Pharmaceutical, Sichuan Omnis Pharmaceutical, Qilu Pharmaceutical, Mylan, Polpharma, Neuraxpharm, Lupin, Hexal AG and Glenmark Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dimethyl Fumarate Delayed-release Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dimethyl Fumarate Delayed-release Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dimethyl Fumarate Delayed-release Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dimethyl Fumarate Delayed-release Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Dimethyl Fumarate Delayed-release Capsules Segment by Company

Teva Pharmaceutical

Sichuan Omnis Pharmaceutical

Qilu Pharmaceutical

Mylan

Polpharma

Neuraxpharm

Lupin

Hexal AG

Glenmark Pharmaceuticals

Cipla

Biogen

Accord Healthcare

Dimethyl Fumarate Delayed-release Capsules Segment by Type

120mg per Unit

240mg per Unit

Dimethyl Fumarate Delayed-release Capsules Segment by Application

Hospital and Clinic

Pharmacy

Other

Dimethyl Fumarate Delayed-release Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dimethyl Fumarate Delayed-release Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dimethyl Fumarate Delayed-release Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dimethyl Fumarate Delayed-release Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dimethyl Fumarate Delayed-release Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dimethyl Fumarate Delayed-release Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dimethyl Fumarate Delayed-release Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dimethyl Fumarate Delayed-release Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dimethyl Fumarate Delayed-release Capsules Industry Trends Table 2. Dimethyl Fumarate Delayed-release Capsules Industry Drivers Table 3. Dimethyl Fumarate Delayed-release Capsules Industry Opportunities and Challenges Table 4. Dimethyl Fumarate Delayed-release Capsules Industry Restraints Table 5. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dimethyl Fumarate Delayed-release Capsules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Manufacturers Table 9. Global Dimethyl Fumarate Delayed-release Capsules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Dimethyl Fumarate Delayed-release Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dimethyl Fumarate Delayed-release Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dimethyl Fumarate Delayed-release Capsules Manufacturers, Product Type & Application Table 13. Global Dimethyl Fumarate Delayed-release Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dimethyl Fumarate Delayed-release Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 120mg per Unit Table 17. Major Manufacturers of 240mg per Unit Table 18. Global Dimethyl Fumarate Delayed-release Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021-2026) & (K Units) Table 20. Global Dimethyl Fumarate Delayed-release Capsules Sales by Type (2027-2032) & (K Units) Table 21. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Type (2021-2026) Table 22. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Type (2027-2032) Table 23. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021-2026) & (K Units) Table 25. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2027-2032) & (K Units) Table 26. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Type (2021-2026) Table 27. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital and Clinic Table 29. Major Manufacturers of Pharmacy Table 30. Major Manufacturers of Other Table 31. Global Dimethyl Fumarate Delayed-release Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021-2026) & (K Units) Table 33. Global Dimethyl Fumarate Delayed-release Capsules Sales by Application (2027-2032) & (K Units) Table 34. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Application (2021-2026) Table 35. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Application (2027-2032) Table 36. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021-2026) & (K Units) Table 38. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2027-2032) & (K Units) Table 39. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Application (2021-2026) Table 40. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Application (2027-2032) Table 41. Global Dimethyl Fumarate Delayed-release Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Dimethyl Fumarate Delayed-release Capsules Sales by Region (2021-2026) & (K Units) Table 43. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Region (2021-2026) Table 44. Global Dimethyl Fumarate Delayed-release Capsules Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Dimethyl Fumarate Delayed-release Capsules Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Dimethyl Fumarate Delayed-release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021-2026) & (K Units) Table 48. North America Dimethyl Fumarate Delayed-release Capsules Sales by Country (2027-2032) & (K Units) Table 49. Europe Dimethyl Fumarate Delayed-release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021-2026) & (K Units) Table 51. Europe Dimethyl Fumarate Delayed-release Capsules Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Dimethyl Fumarate Delayed-release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Dimethyl Fumarate Delayed-release Capsules Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales by Country (2027-2032) & (K Units) Table 58. Global Dimethyl Fumarate Delayed-release Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Region (2021-2026) Table 62. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Region (2027-2032) Table 63. Teva Pharmaceutical Company Information Table 64. Teva Pharmaceutical Business Overview Table 65. Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 67. Teva Pharmaceutical Recent Development Table 68. Sichuan Omnis Pharmaceutical Company Information Table 69. Sichuan Omnis Pharmaceutical Business Overview Table 70. Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 72. Sichuan Omnis Pharmaceutical Recent Development Table 73. Qilu Pharmaceutical Company Information Table 74. Qilu Pharmaceutical Business Overview Table 75. Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 77. Qilu Pharmaceutical Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Mylan Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 82. Mylan Recent Development Table 83. Polpharma Company Information Table 84. Polpharma Business Overview Table 85. Polpharma Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Polpharma Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 87. Polpharma Recent Development Table 88. Neuraxpharm Company Information Table 89. Neuraxpharm Business Overview Table 90. Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 92. Neuraxpharm Recent Development Table 93. Lupin Company Information Table 94. Lupin Business Overview Table 95. Lupin Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Lupin Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 97. Lupin Recent Development Table 98. Hexal AG Company Information Table 99. Hexal AG Business Overview Table 100. Hexal AG Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Hexal AG Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 102. Hexal AG Recent Development Table 103. Glenmark Pharmaceuticals Company Information Table 104. Glenmark Pharmaceuticals Business Overview Table 105. Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 107. Glenmark Pharmaceuticals Recent Development Table 108. Cipla Company Information Table 109. Cipla Business Overview Table 110. Cipla Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Cipla Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 112. Cipla Recent Development Table 113. Biogen Company Information Table 114. Biogen Business Overview Table 115. Biogen Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Biogen Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 117. Biogen Recent Development Table 118. Accord Healthcare Company Information Table 119. Accord Healthcare Business Overview Table 120. Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Product Portfolio Table 122. Accord Healthcare Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Dimethyl Fumarate Delayed-release Capsules Distributors List Table 126. Dimethyl Fumarate Delayed-release Capsules Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Dimethyl Fumarate Delayed-release Capsules Product Image Figure 2. Global Dimethyl Fumarate Delayed-release Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dimethyl Fumarate Delayed-release Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Dimethyl Fumarate Delayed-release Capsules Sales (2021-2032) & (K Units) Figure 5. Global Dimethyl Fumarate Delayed-release Capsules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dimethyl Fumarate Delayed-release Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 120mg per Unit Image Figure 9. 240mg per Unit Image Figure 10. Global Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Type (2021-2032) Figure 13. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Type (2021-2032) Figure 16. Hospital and Clinic Image Figure 17. Pharmacy Image Figure 18. Other Image Figure 19. Global Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Application (2021-2032) Figure 22. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Application (2021-2032) Figure 25. North America Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Country (2021-2032) Figure 27. U.S. Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Country (2021-2032) Figure 32. Germany Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Country (2021-2032) Figure 39. China Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Country (2021-2032) Figure 47. Brazil Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Dimethyl Fumarate Delayed-release Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Dimethyl Fumarate Delayed-release Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Figure 58. North America Dimethyl Fumarate Delayed-release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Figure 60. Europe Dimethyl Fumarate Delayed-release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Dimethyl Fumarate Delayed-release Capsules Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Dimethyl Fumarate Delayed-release Capsules Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 120mg per Unit
  • 240mg per Unit
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Teva Pharmaceutical
  • Sichuan Omnis Pharmaceutical
  • Qilu Pharmaceutical
  • Mylan
  • Polpharma
  • Neuraxpharm
  • Lupin
  • Hexal AG
  • Glenmark Pharmaceuticals
  • Cipla
  • Biogen
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dimethyl Fumarate Delayed-release Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dimethyl Fumarate Delayed-release Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dimethyl Fumarate Delayed-release Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dimethyl Fumarate Delayed-release Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dimethyl Fumarate Delayed-release Capsules Market Dynamics
  1. 2.1 Dimethyl Fumarate Delayed-release Capsules Industry Trends
  2. 2.2 Dimethyl Fumarate Delayed-release Capsules Industry Drivers
  3. 2.3 Dimethyl Fumarate Delayed-release Capsules Industry Opportunities and Challenges
  4. 2.4 Dimethyl Fumarate Delayed-release Capsules Industry Restraints
3 Dimethyl Fumarate Delayed-release Capsules Market by Manufacturers
  1. 3.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dimethyl Fumarate Delayed-release Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dimethyl Fumarate Delayed-release Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dimethyl Fumarate Delayed-release Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dimethyl Fumarate Delayed-release Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Dimethyl Fumarate Delayed-release Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dimethyl Fumarate Delayed-release Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dimethyl Fumarate Delayed-release Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dimethyl Fumarate Delayed-release Capsules Tier 1, Tier 2, and Tier 3
4 Dimethyl Fumarate Delayed-release Capsules Market by Type
  1. 4.1 Dimethyl Fumarate Delayed-release Capsules Type Introduction
  2. 4.1.1 120mg per Unit
  3. 4.1.2 240mg per Unit
  4. 4.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Type
  5. 4.2.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Type (2021-2032)
  7. 4.2.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Type (2021-2032)
  8. 4.3 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type
  9. 4.3.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2021-2032)
  11. 4.3.3 Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Type (2021-2032)
5 Dimethyl Fumarate Delayed-release Capsules Market by Application
  1. 5.1 Dimethyl Fumarate Delayed-release Capsules Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Application
  6. 5.2.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Application (2021-2032)
  8. 5.2.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application
  10. 5.3.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2021-2032)
  12. 5.3.3 Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Application (2021-2032)
6 Global Dimethyl Fumarate Delayed-release Capsules Sales by Region
  1. 6.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Dimethyl Fumarate Delayed-release Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dimethyl Fumarate Delayed-release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dimethyl Fumarate Delayed-release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dimethyl Fumarate Delayed-release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region
  1. 7.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region
  2. 7.1.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032)
  8. 7.2.2 North America Dimethyl Fumarate Delayed-release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Dimethyl Fumarate Delayed-release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dimethyl Fumarate Delayed-release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Sichuan Omnis Pharmaceutical
  8. 8.2.1 Sichuan Omnis Pharmaceutical Company Information
  9. 8.2.2 Sichuan Omnis Pharmaceutical Business Overview
  10. 8.2.3 Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  12. 8.2.5 Sichuan Omnis Pharmaceutical Recent Developments
  13. 8.3 Qilu Pharmaceutical
  14. 8.3.1 Qilu Pharmaceutical Company Information
  15. 8.3.2 Qilu Pharmaceutical Business Overview
  16. 8.3.3 Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  18. 8.3.5 Qilu Pharmaceutical Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Dimethyl Fumarate Delayed-release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Polpharma
  26. 8.5.1 Polpharma Company Information
  27. 8.5.2 Polpharma Business Overview
  28. 8.5.3 Polpharma Dimethyl Fumarate Delayed-release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Polpharma Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  30. 8.5.5 Polpharma Recent Developments
  31. 8.6 Neuraxpharm
  32. 8.6.1 Neuraxpharm Company Information
  33. 8.6.2 Neuraxpharm Business Overview
  34. 8.6.3 Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  36. 8.6.5 Neuraxpharm Recent Developments
  37. 8.7 Lupin
  38. 8.7.1 Lupin Company Information
  39. 8.7.2 Lupin Business Overview
  40. 8.7.3 Lupin Dimethyl Fumarate Delayed-release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lupin Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  42. 8.7.5 Lupin Recent Developments
  43. 8.8 Hexal AG
  44. 8.8.1 Hexal AG Company Information
  45. 8.8.2 Hexal AG Business Overview
  46. 8.8.3 Hexal AG Dimethyl Fumarate Delayed-release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hexal AG Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  48. 8.8.5 Hexal AG Recent Developments
  49. 8.9 Glenmark Pharmaceuticals
  50. 8.9.1 Glenmark Pharmaceuticals Company Information
  51. 8.9.2 Glenmark Pharmaceuticals Business Overview
  52. 8.9.3 Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  54. 8.9.5 Glenmark Pharmaceuticals Recent Developments
  55. 8.10 Cipla
  56. 8.10.1 Cipla Company Information
  57. 8.10.2 Cipla Business Overview
  58. 8.10.3 Cipla Dimethyl Fumarate Delayed-release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cipla Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  60. 8.10.5 Cipla Recent Developments
  61. 8.11 Biogen
  62. 8.11.1 Biogen Company Information
  63. 8.11.2 Biogen Business Overview
  64. 8.11.3 Biogen Dimethyl Fumarate Delayed-release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Biogen Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  66. 8.11.5 Biogen Recent Developments
  67. 8.12 Accord Healthcare
  68. 8.12.1 Accord Healthcare Company Information
  69. 8.12.2 Accord Healthcare Business Overview
  70. 8.12.3 Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Product Portfolio
  72. 8.12.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dimethyl Fumarate Delayed-release Capsules Value Chain Analysis
  2. 9.1.1 Dimethyl Fumarate Delayed-release Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dimethyl Fumarate Delayed-release Capsules Production Mode & Process
  6. 9.2 Dimethyl Fumarate Delayed-release Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dimethyl Fumarate Delayed-release Capsules Distributors
  9. 9.2.3 Dimethyl Fumarate Delayed-release Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst